← Leaderboards
Michael Parks Bogenschutz
University Of New Mexico
$29,464,838
Attributed
$29,464,838
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,464,838 · 8
By mechanism
U10$13,226,290 · 1
UG3$6,417,488 · 1
R01$6,184,393 · 3
P01$2,338,088 · 1
K24$853,642 · 1
R21$444,937 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- Cheryl L Willman$57,213,396
- Cathleen E. Willging$12,973,770
- Robert L Williams$8,477,808
- Scott A. Ness$11,732,063
- Angela Wandinger-Ness$18,901,201
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantAddictionPharmaceutical PreparationsRandomizedNational Institute Of Drug AbusePharmacotherapyClinical Trials NetworkInnovationNew MexicoSubstance Abuse ProblemClinical TrialsResearch ActivityTrainingFundingAlcoholismUniversitiesCostTreatment ProgramResponseAreaAlcohol Use DisorderSamplingMemberEvaluation
Grant awards (44)
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids$3,172,763
UG3 · FY2025 · DA · contact PI
Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.$665,785
R01 · FY2025 · AA · contact PI
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids$3,244,725
UG3 · FY2024 · DA · contact PI
Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.$708,511
R01 · FY2024 · AA · contact PI
Topiramate as a treatment for Co-occurring AUD and PTSD$433,819
P01 · FY2022 · AA · contact PI
Topiramate as a treatment for Co-occurring AUD and PTSD$501,417
P01 · FY2021 · AA · contact PI
Topiramate as a treatment for Co-occurring AUD and PTSD$501,417
P01 · FY2020 · AA · contact PI
Topiramate as a treatment for Co-occurring AUD and PTSD$501,417
P01 · FY2019 · AA · contact PI
Topiramate as a treatment for Co-occurring AUD and PTSD$400,018
P01 · FY2018 · AA · contact PI
Effects of cannabidiol in alcohol use disorder-Resubmission-1$201,281
R21 · FY2018 · AA · contact PI
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs$640,358
R01 · FY2017 · DA · contact PI
Effects of cannabidiol in alcohol use disorder-Resubmission-1$243,656
R21 · FY2017 · AA · contact PI
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs$679,534
R01 · FY2016 · DA · contact PI
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs$685,773
R01 · FY2015 · DA · contact PI
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs$632,425
R01 · FY2014 · DA · contact PI
Clinical Trials Network: Southwest Node$1,097,298
U10 · FY2013 · DA · contact PI
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs$612,048
R01 · FY2013 · DA · contact PI
Clinical Trials Network: Southwest Node$1,105,058
U10 · FY2012 · DA · contact PI
Clinical Trials Network: Southwest Node$244,000
U10 · FY2012 · DA · contact PI
Clinical Trials Network: Southwest Node$1,122,294
U10 · FY2011 · DA · contact PI
Clinical Trials Network: Southwest Node$412,566
U10 · FY2011 · DA · contact PI
Clinical Trials Network: Southwest Node$253,982
U10 · FY2011 · DA · contact PI
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders$176,729
K24 · FY2011 · AA · contact PI
Clinical Trials Network: Southwest Node$1,124,902
U10 · FY2010 · DA · contact PI
Clinical Trials Network: Southwest Node$770,000
U10 · FY2010 · DA · contact PI
Clinical Trial Network: Southwest Node$193,311
U10 · FY2010 · DA · contact PI
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders$173,764
K24 · FY2010 · AA · contact PI
Clinical Trial Network: Southwest Node$923,070
U10 · FY2009 · DA · contact PI
12-Step Facilitation for the Dually Diagnosed$204,276
R01 · FY2009 · AA · contact PI
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders$171,132
K24 · FY2009 · AA · contact PI
Clinical Trial Network: Southwest Node$99,973
U10 · FY2009 · DA · contact PI
Clinical Trial Network: Southwest Node$899,295
U10 · FY2008 · DA · contact PI
Clinical Trial Network: Southwest Node$343,687
U10 · FY2008 · DA · contact PI
12-Step Facilitation for the Dually Diagnosed$321,315
R01 · FY2008 · AA · contact PI
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders$167,875
K24 · FY2008 · AA · contact PI
Clinical Trial Network: Southwest Node$898,609
U10 · FY2007 · DA · contact PI
12-Step Facilitation for the Dually Diagnosed$339,227
R01 · FY2007 · AA · contact PI
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders$164,142
K24 · FY2007 · AA · contact PI
Clinical Trial Network: Southwest Node$127,491
U10 · FY2007 · DA · contact PI
Clinical Trials Network: New Mexico Node$1,250,000
U10 · FY2006 · DA · contact PI
Clinical Trials Network: New Mexico Node$1,153,931
U10 · FY2006 · DA · contact PI
12-Step Facilitation for the Dually Diagnosed$336,371
R01 · FY2006 · AA · contact PI
Clinical Trials Network: New Mexico Node$1,206,823
U10 · FY2005 · DA
12-Step Facilitation for the Dually Diagnosed$358,770
R01 · FY2005 · AA